(Q37963916)

26 August 2017

title

Therapies using anti-angiogenic peptide mimetics of thrombospondin-1. (English)

1 reference

26 August 2017

main subject

angiogenesis inhibitor

1 reference

Jack Henkin

1

1 reference

26 August 2017

Olga V Volpert

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

5 December 2011

1 reference

Expert Opinion on Therapeutic Targets

26 August 2017

published in

1 reference

26 August 2017

volume

15

1 reference

26 August 2017

issue

12

1 reference

26 August 2017

page(s)

1369-1386

1 reference

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

The biphasic nature of nitric oxide responses in tumor biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondins function as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-based antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Integrin-associated protein stimulates alpha2beta1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Structures of thrombospondins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

The N-terminus of thrombospondin: the domain stands apart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Nuclear factor of activated T cells balances angiogenesis activation and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Molecular mechanisms for discrete nitric oxide levels in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1: a physiological regulator of nitric oxide signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Reduced expression of the TSP1 gene and its association with promoter hypermethylation in gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 is a transcriptional repression target of PRMT6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Oxidative stress-induced attenuation of thrombospondin-1 expression in primary rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Glucose and insulin modify thrombospondin 1 expression and secretion in primary adipocytes from diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Integrin-associated protein and thrombospondin-1 as endothelial mechanosensitive death mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Proinflammatory cytokines (interleukin-1 beta and tumor necrosis factor-alpha) down regulate synthesis and secretion of thrombospondin by human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Identification of AKT-regulated genes in inducible MERAkt cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Beta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

E2F-1 directly regulates thrombospondin 1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Regulation of thrombospondin-1 expression through AU-rich elements in the 3'UTR of the mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Dermatological aspects of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Methylation and silencing of the Thrombospondin-1 promoter in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Ultrastructural Localization of CD36 in Human Hepatic Sinusoidal Lining Cells, Hepatocytes, Human Hepatoma (HepG2-A16) Cells, and C32 Amelanotic Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Angiogenic factors in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondins in the heart: potential functions in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 expression is increased during follicular atresia in the primate ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin plays a vital role in the immune privilege of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Impaired expression of thrombospondin-1 in eyes with age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin modules and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Increased Risk of Colorectal Cancer Due to Interactions Between Meat Consumption and the CD36 Gene A52C Polymorphism Among Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.640319

10.1517/14728222.2011.640319

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference